ESR1 and breast cancer: Thus, OAds encoding the human sodium/iodide symporter (hNIS), a transmembrane protein that can transport iodide ions across cell membrane, have been used for targeting of breast cancer stem cells (BCSC)-enriched estrogen receptor-positive (ER+) paclitaxel-resistant [92] or pancreatic cancer cells [93].